On behalf of European Rare Disease community, c4c submits a shared response to the FDA consultation about a global clinical trials network in rare diseases. On May 29th this year, the FDA opened a consultation to obtain information and comments from patients, patient advocates, the scientific community, health professionals, other regulatory and health authorities in the…
We are working to ensure children have the same rights as adults to access high quality, evidence-based medicines and health care services. We are fully committed to increasing high quality paediatric research.
We are working to ensure children have the same rights as adults to access high quality, evidence-based medicines and health care services. We are fully committed to increasing high quality paediatric research.
We are working to ensure children have the same rights as adults to access high quality, evidence-based medicines and health care services. We are fully committed to increasing high quality paediatric research.
We are working to ensure children have the same rights as adults to access high quality, evidence-based medicines and health care services. We are fully committed to increasing high quality paediatric research.
c4c will host an online ‘Train the Trainers’ workshop on 16-17 September 2020. This workshop is open to all patients and patient representatives who are interested in finding out more about the life cycle of medicines and how to get involved within the c4c project. To attend this workshop – apply here! The ‘Train the…
c4c is about to launch the third periodic edition of the PAEDIATRIC GCP BASIC ONLINE TRAINING COURSE. It will be available to the c4c network’s clinical site staff and healthcare professionals involved in the c4c funded clinical trials. If you are interested, please get in contact with your National Hub. The PAEDIATRIC GCP BASIC ONLINE…
Since the announcement of the conect4children (c4c) Consortium’s first portfolio of research studies in April 2019, it is with regret that we inform you the Matrix-directed therapy in children with osteogenesis imperfecta (MOI) study, will no longer feature as part of the c4c portfolio of studies. The c4c Consortium undertook a competitive selection process of…
c4c launches a new video to explain how young people living with a disease can make a difference in helping European regulatory authorities to develop better medicines and evaluate new treatments. You may have seen our earlier video on how children, young people and families can get involved in the c4c project – now we…
c4c is excited to launch the first edition of two new online training courses – TRIAL START UP and MONITORING. This training is available to the c4c network’s clinical site staff and healthcare professionals involved in the c4c funded clinical trials. If you are interested, please get in contact with your National Hub. Both courses will…